Atara Biotherapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Atara Biotherapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Atara Biotherapeutics Inc Strategy Report
- Understand Atara Biotherapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Atara Biotherapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 26 Jan 2022 | Fujifilm Holdings Acquires T-Cell Operations and Manufacturing Facility (ATOM) from Atara Biotherapeutics | Asset Transaction |
Fujifilm Holdings Corp
|
Atara Biotherapeutics Inc |
| 26 Nov 2021 | Atara Biotherapeutics to Raise up to USD100 Million in Public Offering of Shares | Equity Offering | - |
Atara Biotherapeutics Inc |
| 02 Oct 2021 | Pierre Fabre Medicament Enters into Licensing Agreement with Atara Biotherapeutics | Licensing Agreement |
Pierre Fabre Medicament SA
|
Atara Biotherapeutics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer